Omega 3 fatty acids for the treatment of dementia and cognitive impairment


Dionisi, F. and Calder, P. C. (2011) Omega 3 fatty acids for the treatment of dementia and cognitive impairment Cochrane Database of Systematic Reviews, (2) (doi:10.1002/14651858.CD009002).

Download

Full text not available from this repository.

Description/Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objective

To evaluate the effect of omega 3 FA supplementation on cognitive functions in patients with dementia or mild cognitive impairment.

Secondary objectives

To assess the effect of omega 3 FA on global disease severity, neuropsychiatric symptoms, quality of life and performance of activities of daily living (ADLs) and to assess the safety and acceptability of omega 3 FA supplementation in patients with dementia and mild cognitive impairment

Item Type: Article
Digital Object Identifier (DOI): doi:10.1002/14651858.CD009002
ISSNs: 1469-493X (print)
Related URLs:
Subjects:
Organisations: Human Development & Health
ePrint ID: 337273
Date :
Date Event
16 February 2011e-pub ahead of print
Date Deposited: 20 Apr 2012 15:43
Last Modified: 17 Apr 2017 17:17
Further Information:Google Scholar
URI: http://eprints.soton.ac.uk/id/eprint/337273

Actions (login required)

View Item View Item